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The theme of this dissertation is the potential impact of pre- and post-natal lead 
exposure on child growth and maturation. Maternal bone lead has been inversely 
associated with physical growth in infants and young children, but no study has examined 
whether this association persists throughout preschool years. In addition, lead exposure 
has been implicated as a possible contributing factor to delayed puberty in cross-sectional 
studies.  
Taking advantage of a long-running birth cohort study in Mexico City that used 
maternal bone lead, a novel biomarker of prenatal lead exposure, we studied the 
association of lead with child weight trajectory from birth to 5 years, adjusting for 
postnatal lead exposure. Second, we identified critical windows of lead exposure 
susceptibility on children’s height and body mass index (BMI) at 4 years of age. Third, 
we examined the association of prenatal lead exposure with puberty onset among a subset 
of 43 girls and 31 boys at ages 6 to 15 years. 
Prenatal lead exposure was associated with a sustained decrease in girls’ but not 
boys’ weight over time, independent of postnatal lead exposure and adjusting for several 
confounders and predictors of child’s weight. Second, we found that the most sensitive 
window of lead exposure on skeletal growth during development (measured by height) 
was infancy (birth to 24 months). Lead exposure was not associated with children’s 
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attained BMI at 4 years of age. Preliminary findings from the follow-up study of youth 
aged 6 to 15 years do not support an association of prenatal lead exposure with pubertal 
onset, but these findings are limited by sample size. 
Lead exposure at current environmental levels remains an important public health 
issue; it is associated with childhood weight and height deficits. Future research will 
investigate its association with onset of puberty in a larger sample from this cohort. The 











The theme of this dissertation is the potential impact of pre- and post-natal lead 
exposure on child physical growth and sexual maturation. Although lead is one of the 
best studied pollutants worldwide, its long-term effects on physical growth and 
maturation are not yet fully understood. This issue is of major public health importance 
as low-level environmental lead exposure remains common in both developed and 
developing countries (Tong, von Schirnding et al. 2000; Lanphear 2007; Bellinger 2008; 
Rossi 2008).  
The objective of this research is to understand the association of lead with 
different aspects of physical growth in early childhood. Does lead depress growth; if so, 
which anthropometric measures (or indices) does it affect (weight, height, BMI)? What 
are the potential exposure windows of susceptibility of lead on growth in children before 
school entry? Is depressed growth followed by catch-up growth? Finally, is lead exposure 
associated with a delayed onset of puberty as suggested by a few epidemiological studies 




Lead exposure: a continuing public health problem 
 
Effects and global sources of lead  
 
Environmental lead exposure remains an important issue worldwide (Tong, von 
Schirnding et al. 2000; Gordon, Mackay et al. 2004; Rossi 2008). It health effects are 
systemic and include reproductive, cardiovascular, renal, neurodevelopmental 
consequences (ATSDR 2007). The global burden of mental retardation due to lead has 
been estimated to represent 1% of the global burden of disease and 2% of the total 
cardiovascular disease burden (Fewtrell, Prüss-Üstün et al. 2004).  
Even though worldwide lead exposure has decreased tremendously in the past 
decades (Pirkle, Brody et al. 1994; Hwang, Ko et al. 2004; Gulson, Mizon et al. 2006), 
mainly due to the phasing out of leaded gasoline, lead is still ubiquitous and often found 
in flaking lead-based paints (Mathee, Singh et al. 2009), candies (CDC 2002; Medlin 
2004), cosmetics (Al-Ashban, Aslam et al. 2004), traditional lead-glazed ceramics used 
in the preparation and serving of food (Sabouraud, Coppéré et al. 2009), herbal remedies 
(Obi, Akunyili et al. 2006), canned foods and beverages (lead solder) (Maduabuchi, 
Nzegwu et al. 2006), toys (Greenway and Gerstenberger 2010), and can affect 
communities residing near smelters (Hegde, Sridhar et al. 2010) and battery recycling 
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Sources of lead in Mexico City 
 
Leaded gasoline is one of the environmental sources of lead to which our study 
cohort has been exposed. It was phased out in Mexico between 1991 and 1997 (Romieu, 
Palazuelos et al. 1994). Lead is still present in the bodies of the mothers in our cohort 
because of the long retention time of lead in bone (see section on Exposure assessment). 
Another prevalent ongoing source of lead exposure in Mexico City is the continued use 
of traditional lead-glazed ceramics in the preparation and serving of food (Romieu, 
Palazuelos et al. 1994; Chaudhary-Webb, Paschal et al. 2003). Exposure can occur 
through ingestion (from lead-glazed ceramics or leaded gasoline) or inhalation (leaded 
gasoline). 
 
Environmental lead exposure, growth, and development 
 
Auxology: the study of growth  
 
Growth is determined by both environment and genetics (the relationship can be 
defined as an interaction) (Tanner 1990). Genetics (partly reflected by parental size) 
determines growth potential, while environment modulates how much of this growth 
potential is attained. Several environmental factors affect growth such as nutrition 
(Boulton, Garnett et al. 1999), chronic diseases in childhood, lifestyle (physical activity), 
and pollutants. Socio-economic status (SES) has been used as a proxy variable for these 
environmental factors. Child growth may mirror disparities in exposures and 
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environmental factors (Tanner 1990). Thus growth of children can be regarded as a 
“mirror of society” (Tanner 1987).  
Growth can be defined as both physical growth (as measured by weight and 
height) as well as development (maturation). The outcomes examined in the following 
chapters are weight, height, BMI, and sexual maturation as measured by puberty onset.  
Height reflects child nutrition and health status (chronic infections, illnesses etc). 
Weight-for-age is a useful indicator to evaluate if a child is underweight or severely 
underweight (WHO 1995). BMI is an index of weight relative to height (kg/m
2
). It is 
used as a screening tool for overweight and obesity. High BMI correlates with high fat 
mass, but overall BMI does not accurately classify the percentage of fat across the 
distribution. In children, fat mass and therefore BMI change with age: BMI gets lower 
during the preschool years, then increases during adiposity rebound, and then continues 
to increase throughout adolescence. Percentiles of BMI-for-age are a better tool to screen 
for overweight and obese status. Percentiles of BMI-for-age are constructed by 
comparing the BMI of a specific child to the BMI distribution of a reference population 




 percentile is an 
indicator for overweight; and a BMI-for-age ≥95
th
, an indicator for obesity. BMI-for-age 
≥95
th
 percentile is a moderately sensitive and specific indicator of adiposity among 
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Endocrinological regulation of postnatal physical growth 
 
Stimulation of physical growth occurs through the pulsatile release of growth 
hormone by the anterior pituitary. The release of growth hormone in turn is coordinated 
by somatostatin, which acts as a growth inhibitor, and growth hormone releasing 
hormone (GHRH), which acts as a growth stimulant (Thorner, Vance et al. 1989). 
Somatostatin and GHRH are of hypothalamic origin. Synthesis and secretion of GH 
arises by GHRH binding to its receptor (Thorner, Vance et al. 1989).  
Receptors for growth hormone are present on each cell of the human body. 
Through cell signaling in several organs and tissues, growth hormone leads to the 
production of somatomedin (also known as insulin-like growth factor, IGF). IGF-1 
contributes to bone growth by increased protein synthesis and cell proliferation 
(Hindmarsh 1988; Tanner 1990). This hormone also controls somatostatin and GHRH 
through a feedback loop (Thorner, Vance et al. 1989). 
Growth is also a result of gonadal steroids (namely, testosterone and estradiol) 
(Hindmarsh 1988). During puberty, the amplitude (but not frequency) of growth hormone 
pulses increases, and is primarily responsible for the adolescent height spurt (Tanner 
1990).  
Hormonal regulation of physical growth can be disrupted by lead. Animal studies 
have demonstrated that lead causes a decrease in circulating plasma IGF-1 levels (Ronis, 
Badger et al. 1998) and inhibits binding of growth hormone releasing hormone to its 
receptor (Camoratto, White et al. 1993). 
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Endocrinological control of puberty 
 
Among humans, puberty occurs as a result of the activation of the hypothalamic-
pituitary-gonadal (HPG) axis and hypothalamic-pituitary-adrenal (HPA) axis. Leptin has 
been hypothesized to be a permissive factor in the activation of the HPA and HPG axes 
as leptin levels increase during puberty (Styne 2001; Witchel and Plant 2004). Another 
suspected trigger of puberty is skeletal age (Styne and Grumbach 2003; Witchel and 
Plant 2004). Puberty begins when the central nervous system (CNS) signals the 
hypothalamus to discharge gonadotropin releasing hormone (GnRH) (Buck Louis, Gray 
et al. 2008). This hormone triggers the pituitary to release luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH), which stimulate the gonads (testes and ovaries) to 
produce androgen and estrogen. These sex hormones lead to pubertal changes and to the 
growth and maturation of the penis, pubic hair, testes, breasts, ovaries, and uterus. 
Similarly, adrenarche is initiated by the CNS, which simulates the hypothalamus. 
Adrenocorticotropin releasing hormone (CRH) is discharged from the hypothalamus and 
triggers the pituitary to release adrenocorticotropin releasing hormone (ACTH). ACTH 
stimulates the adrenal cortex to release androstenedione and dehydroepiandrosterone 
(DHEA), which lead to the development of secondary sexual characteristics among males 









Bones are comprised of three types of cells: osteoblasts, octeocytes, and 
osteoclasts. Osteoblasts are bone-forming cells involved in the synthesis of type I 
collagen as well as alkaline phosphatase. At the bone surface osteoblasts create new bone 
through mineralization using calcium and phosphate to form hydroxyapatite (Stini 1998). 
At this point, an element such as lead can be deposited in the remodeled bone (Stini 
1998). Some of the osteoblasts then remain in cortical bone as osteocytes. Osteocytes 
work as multinucleate units to transport minerals, connect with nutrient capillaries, and 
communicate with surface osteoblasts (Shoback, Marcus et al. 2001). During the life 
course, bone remodeling is a dynamic interplay between bone resorbtion (osteoclasts) and 
bone formation (osteoblasts) (Shoback, Marcus et al. 2001).  
During childhood and puberty, linear growth (bone elongation) occurs as a result 
of cartilage development at the ends of the diaphysis in the long bones the epiphysial 
growth plate. Chondrocytes are cartilage-forming cells that produce collagen. Osteoblasts 
complete the final part of bone elongation by mineralization of collagen (Puzas, Sickel et 
al. 1992). Specific growth factors (such as insulin-like growth factor I (IGF-I), and 
transforming growth factor-beta1 (TGF-β1)) regulate chondrocyte proliferation (Zuscik, 
Pateder et al. 2002). These growth factors are themselves controlled by signaling 
pathways (such as the activator protein 1 (AP-1)) essential for chondrocyte maturation 
and regulation. At the end of adolescence, when linear growth is complete, estrogen 
signals the close of the growth plate (Stini 1998; Chagin and Sävendahl 2009). Thus, 
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environmental insults affecting long bones occurring during development tend to result in 
permanent effects on attained height. 
 
Lead and physical growth 
 
Physical growth during childhood begins at birth with the product of fetal growth 
and is then shaped by the postnatal environment. Fetal and postnatal growth can be 
impacted by a number of factors, one of them being environmental insults such as lead. 
Altered growth rate might have significant consequences for the development of the 
child. Reduced growth rate, for example, might lead to a subsequent catch-up growth in 
childhood, which in turn, might be a risk factor for adult disease outcomes such as 
cardiovascular diseases, obesity, and hypertension (Eriksson, Forsén et al. 1999).   
Catch-up growth has been observed among children exposed to high lead levels in 
utero but low levels postnatally. High lead exposure in utero has been associated with 
decrements in attained length at 15 months (Shukla, Bornschein et al. 1989); but lower 
subsequent lead levels were associated with catch-up from 15 to 33 months (Shukla, 
Dietrich et al. 1991). Schell and colleagues found that the effect of lead on several 
anthropometric indices at 12 months was both exposure-and time dependent and could be 
wholly or partially reversible (Schell, Denham et al. 2009). 
 
Prenatal lead exposure and growth 
In epidemiologic studies, prenatal lead exposure measured by maternal bone 
(patella and tibia) lead levels has been associated with smaller size at birth (weight, 
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length, and head circumference), weight attained at one month of age, and weight gain 
between birth and one month of age (Gonzalez-Cossío, Peterson et al. 1997; Sanín, 
Gonzalez-Cossío et al. 2001; Hernández-Avila, Peterson et al. 2002). Prenatal lead 
exposure measured by maternal blood lead levels during pregnancy or by cord blood lead 
levels also has been associated with decrements in physical growth of children in some 
studies (Shukla, Bornschein et al. 1989; Zentner, Rondo et al. 2006; Lamb, Janevic et al. 
2008; Schell, Denham et al. 2009), but not in others (Greene and Ernhart 1991). 
 
Postnatal lead exposure and growth  
Postnatal lead exposure measured by child blood lead levels has been associated 
with delays in physical growth in some studies (Schwartz, Angle et al. 1986; Little, Snell 
et al. 1990; Frisancho and Ryan 1991; Shukla, Dietrich et al. 1991; Kafourou, Touloumi 
et al. 1997; Ballew, Khan et al. 1999; Little, Spalding et al. 2009), but not in others 
(Sachs and Moel 1989; Greene and Ernhart 1991).  
 
These studies have examined population-wide lead exposure at levels around the 
U.S. Centers for Disease Control and Prevention (CDC) screening level of 10 µg/dL 
(CDC 1991) but not at occupational levels. Results of these studies, however, were 
limited by lead exposure measures. The biomarkers employed were not reflective of 
integrated lead exposure during pregnancy. Second, few studies incorporated repeated 
anthropometry through a longitudinal design. Finally, some studies were limited by their 
sample size.  
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Lead and puberty timing 
 
Lead exposure in adolescence has been associated with delays in the timing of 
puberty in cross-sectional studies in nationally representative samples of U.S. females 
(Selevan, Rice et al. 2003; Wu, Buck et al. 2003; Gollenberg, Hediger et al. 2010), and 
among Akwesasne Mohawk girls in New York State (Denham, Schell et al. 2005); but 
not among inner-city U.S. females (Wolff, Britton et al. 2008). Among boys, one study in 
Russia suggests an association of lead with pubertal characteristics (Hauser, Sergeyev et 
al. 2008; Williams, Sergeyev et al. 2010). A major limitation of these studies is the cross-






Several biomarkers of prenatal lead exposure have been used in epidemiological 
studies as described above. Maternal bone lead has been demonstrated to be one of the 
most useful measures of cumulative fetal lead exposure; which in turn has been found in 
several studies to be best predictive of adverse postnatal outcomes such as intelligence 
quotient (IQ) (Gomaa, Hu et al. 2002) and linear growth (Hernández-Avila, Peterson et 
al. 2002).   
The absorbed dose of lead is distributed in the blood, soft tissues (such as liver, 
kidneys, lungs, brain, spleen, muscles, and heart), and mineralizing tissues (such as bones 
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and teeth). However, most of the lead in the body is stored in the bones (90 to 95% 
among adults and 70 to 80% among children) for years to decades (Barry and Mossman 
1970). Measurement of lead in bones represents historical exposure. The cortical bone 
(mid-tibial shaft) has more mineral collagen content than the trabecular bone (patella or 
knee cap) and lead accumulates slower in this bone component. Trabercular bone is more 
vascularized, and thus reflects more recent lead exposure than cortical bone (Hu, Milder 
et al. 1989; Hu, Rabinowitz et al. 1998). Due to their different physiology, lead 
metabolism behavior, and mineral turn-over rates, measurements were carried out in both 
the mid-tibial shaft (cortical bone) and the patella or knee cap (trabercular bone) in our 
study. 
Most of the lead in blood is bound to red blood cells (Goyer 1990). Lead 
concentrations in the plasma reflect the amount of circulating lead available to cross the 
placenta by passive diffusion (Chuang, Schwartz et al. 2001). During pregnancy and 
lactation, the calcium needs of the developing fetus and infant are met by the increased 
resorption of maternal calcium stores in the bone and increased absorption in the 
gastrointestinal tract (Sowers, Corton et al. 1993). Because lead is stored in the bones, it 
is mobilized from the bones to plasma and crosses the placenta during pregnancy and 
lactation (Goyer 1990; Gulson, Jameson et al. 1997). Whole blood lead measurements 
reflect recent exposure. In fact, the half-life of lead in blood is about 35 days 
(Rabinowitz, Wetherill et al. 1976). Endogenous sources of lead – from the bones for 
example – also contribute to lead in blood. In this study, we used maternal bone lead to 
assess prenatal lead exposure and child blood lead to assess postnatal lead exposure.  
 




The sample population for this thesis consists of 3 sequentially-enrolled 
longitudinal pooled birth cohorts recruited between 1994 and 2005 at maternity hospitals 
serving low-to-moderate income populations in Mexico City (Mexican Social Security 
Institute, Manuel Gea González Hospital, and National Institute of Perinatology). Starting 
in 2007, participants in the 3 birth cohorts were subsequently invited for a prospective 
follow-up after the child was at least 6 years of age. This study population is part of the 
ELEMENT (Early Life Exposures in Mexico to Environmental Toxicants) project 
(Figure I-1). 
 
Figure I-1: ELEMENT study cohorts 
 
In this dissertation, cohorts 2PL and 2BI are referred to as Cohort 2A and 2B 
respectively.  
The x’s correspond to the time of study visit. For example, Cohort 1 mothers were 
recruited during the 3
rd
 trimester of pregnancy. 
Children in Cohort 1 were followed up until 4 years of age whereas those in Cohorts 2 
(PL and BI) and 3 until 5 years of age. 
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Cohort 1 was a randomized control trial of the effect of calcium supplementation 
on blood lead levels during lactation. Study methods have been extensively described 
elsewhere (Gonzalez-Cossío, Peterson et al. 1997; Téllez-Rojo, Hernández-Avila et al. 
2002; Hernández-Avila, Gonzalez-Cossío et al. 2003). Briefly, 617 mother-infant pairs 
were recruited between 1994 and 1995 and followed until 1997. Cohort 2 comprised two 
groups, the first (Cohort 2A, n=327) recruited pre-pregnancy and followed between 1997 
and 2000, and the second (Cohort 2B, n=462) was recruited during pregnancy and 
followed between 1999 and 2000. Data collection methods have been described 
elsewhere (Téllez-Rojo, Hernandez-Avila et al. 2004; Hu, Téllez-Rojo et al. 2006). The 
557 mothers in Cohort 3 were enrolled in a randomized trial of calcium supplementation 
during pregnancy (Ettinger, Lamadrid-Figueroa et al. 2009) and their children followed 
from 2000 to 2007.  
Similar exclusion criteria were applied to the 3 cohorts, such as, living outside of 
Mexico City, a physician’s diagnosis of current multiple pregnancies, gestational 
diabetes, seizure disorder requiring daily medications except for other criteria described 
elsewhere (Gonzalez-Cossío, Peterson et al. 1997; Téllez-Rojo, Hernandez-Avila et al. 
2004; Ettinger, Lamadrid-Figueroa et al. 2009), as shown in Table I-1. 
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Table I-1: Exclusion criteria by cohort 
Exclusion criteria 
Cohort 
1 2A 2B 3 
No intention to breastfeed x    
Living outside of Mexico City x x x x 
Having plans to leave Mexico City in the following 
5 years 
 x x  
Not trying to become pregnant or no positive B-
human chorionic gonadotropin test 
 x   
Conditions related to calcium metabolism and 
requirements 
x    
Not agreeing to participate in follow-up  x x x 
Multiple fetuses/ a physician’s diagnosis of current 
multiple pregnancy 
x x ‡ x 
Preeclampsia, or pregnancy-related hypertensive 
disorders 
x x x x 
Psychiatric disease x x   
Kidney or cardiac disease x x  x 
Gestational diabetes x x x x 
History of repeated urinary infections x x   
Family or personal history of kidney stone formation x    
Seizure disorder requiring daily medications x x x x 
Use of corticosteroids x    
Blood pressure >140 mm Hg systolic or > 90 mm 
Hg diastolic 
x    
Premature neonates (<37 weeks) or newborns with 
low birth weight (<2000 g) 
x    
Pregnancy of more than 20 weeks’ gestation  x ‡  
Pregnancy of more than 14 weeks’ gestation   ‡ x 
Daily consumption of alcoholic beverages  x  x 
Addiction to illegal drugs  x  x 
Continuous use of prescription drugs  x  x 
Not intending to become pregnant ‡ x  x 
Presenting with a high-risk pregnancy  x x x 
Infant with an Apgar score at 5 minutes of 6 or under x    
Conditions requiring infant placement in a neonatal 
intensive care unit 
x    
‡ Refers to not applicable. 
 
The 3 birth cohorts were pooled for the purposes of this study. Although each 
cohort was studied for distinct specific aims, combining the three cohorts was possible 
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through the use of common methods for recruiting subjects, and common measures of 
pre-and post-natal lead exposure, covariates, and anthropometry. The published 
manuscripts that will result from this dissertation are our research group’s first study that 




Weight and length of nude newborns were measured within 12 hours of delivery 
by experienced obstetric nurses. At subsequent study visits, children’s weight and height 
were collected by trained staff (Lohman, Roche et al. 1988) using standard protocols 
(Habicht 1974). Calibrated beam scales (Oken, Model TD16, Naucalpan, México) were 
used and read to the nearest 10 grams (g). Maternal height was obtained at 1-month 
postpartum using professional scales (PAME, Puebla, Puebla) read to the nearest 
millimeter (mm). Maternal calf circumference was used as a proxy for maternal body 
size, consistent with previous research (Gonzalez-Cossío, Peterson et al. 1997). Maternal 
calf circumference was measured at 1-month postpartum with plastic-covered fabric 
measuring tapes read to the nearest mm. As described elsewhere (Gonzalez-Cossío, 
Peterson et al. 1997), standardization exercises were performed until the project staff 
reached imprecision errors (3 mm for calf circumferences and 2.2 mm for height) equal 









Chapter II investigates the association of maternal bone lead with repeated 
measures of weight from birth to 5 years of age, controlling for child blood lead. Taking 
advantage of the longitudinal study design, we are able to disentangle the association of 
both pre- and post-natal lead exposure with attained weight over a period of 5 years. 
Chapter III explores windows of lead exposure susceptibility during growth 
through the use of lead exposure histories. The identified windows include prenatal, 
infancy (from birth to 24 months), and early childhood (from 30 to 48 months). The 
growth outcomes investigated are height and BMI at 4 years of age. 
The aim of Chapter IV is to describe the study design and explore the association 
between prenatal lead exposure and puberty onset among a subset of the same children 
followed-up at 6 to 15 years of age.  
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Cumulative prenatal lead exposure as measured by maternal bone lead burden has 
been associated with smaller weight of offspring at birth and 1 month of age, but no study 
has examined whether this effect persists into early childhood. We investigated the 
association of maternal bone lead, a biomarker of cumulative prenatal lead exposure, with 
children’s attained weight over time from birth to 5 years of age. 
 
Methods:  
Children were weighed at birth and at several intervals up until 12 months of age 
and every 6 months from 12 to 60 months. Maternal tibia and patella lead were measured 
at 1-month postpartum using in vivo K-X-ray fluorescence. Varying coefficient models 
with random effects were used to assess the effect of tibia and patella lead on weight 
trajectories of 522 males and 477 females born between 1994 and 2005 in Mexico City.  
 
Results: 
After controlling for breastfeeding duration, maternal anthropometry, and socio-
demographic characteristics, a 1 standard deviation increase in patella lead was 
25 
 
associated with a 130.9 g decrease in weight (95% CI= -227.4 to -34.4) among females 
and a 13.0 g non-significant increase in weight among males (95% CI= -73.7 to 99.9) at 5 
years of age. These effects were similar after controlling for concurrent blood lead levels 
between birth and 5 years (171.6 g decrease in weight among females, 95% CI= -275.2 to 




Maternal post-partum bone lead was associated with lower weight over time 
among female but not male children up to 5 years of age.  




 The developmental origins hypothesis stipulates that constraints on fetal growth 
can have lasting impact on postnatal growth and related chronic diseases (Eriksson, 
Forsén et al. 1999; Barker 2006). Although lead levels have decreased in the last few 
decades in the United States (Jones, Homa et al. 2009) and in other countries (Hwang, 
Ko et al. 2004; Gulson, Mizon et al. 2006), environmental lead continues to be a public 
health problem that may restrict both fetal and child growth (Hernández-Avila, 
Peterson et al. 2002). Maternal lead exposure during pregnancy has been related to fetal 
growth, as reflected by infant size at birth (Andrews, Savitz et al. 1994; Jelliffe-
Pawlowski, Miles et al. 2006). Prenatal lead exposure measured by maternal blood lead 
has been associated with decreases in children’s weight-for-age z-scores at 6 months 
(Schell, Denham et al. 2009). Perinatal blood lead exposure has been associated with 
decrements in weight-for-age, weight-for-length, and length at 6 and 15 months of age 
followed by a catch-up growth at 12 and 33 months respectively if postnatal exposure 
was low (Shukla, Bornschein et al. 1989; Shukla, Dietrich et al. 1991; Schell, Denham 
et al. 2009).  
 
 The association of blood lead levels (pre- and post-natal) with child height has 
been more consistent than with weight (Andrews, Savitz et al. 1994; Peterson, Salganik et 
al. 2004; Schell, Gallo et al. 2006), although inferences from some studies have been 
limited by their cross-sectional design (Schwartz, Angle et al. 1986; Frisancho and Ryan 
1991; Kafourou, Touloumi et al. 1997; Ballew, Khan et al. 1999). Less attention has been 
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paid to prenatal lead exposure as measured by a cumulative marker of maternal lead 
burden and its relationship to child growth over time. Mobilization of lead in the bones is 
a source of endogenous exposure after external lead exposure has ceased (Gulson, 
Jameson et al. 1997; Gulson, Pounds et al. 1999), especially during pregnancy and 
lactation, when the calcium needs of the developing fetus and infant are partially met by 
the resorption of maternal calcium stores in the bone.  
 Maternal bone lead burden has been associated with a decrease in birth weight 
(Gonzalez-Cossío, Peterson et al. 1997) and lower weight gain from birth to 1 month of 
age and lower attained weight at 1 month (Sanín, Gonzalez-Cossío et al. 2001). However, 
no study has examined whether the association of maternal bone lead with weight persists 
into early childhood.  
The present study aims to discern the longitudinal effect of prenatal lead exposure 
as measured by maternal bone lead burden on weight over time from birth to 5 years 
adjusted for postnatal lead exposure. We hypothesized that prenatal lead exposure would 
lead to decreases in repeated measures of weight over time.  
 




Similar exclusion criteria were applied to the three cohorts, such as: living outside 
of Mexico City, a physician’s diagnosis of current multiple pregnancies, gestational 
diabetes, and seizure disorder requiring daily medications (Gonzalez-Cossío, Peterson et 
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al. 1997; Téllez-Rojo, Hernandez-Avila et al. 2004; Ettinger, Lamadrid-Figueroa et al. 
2009). For purposes of this study, we applied additional eligibility criteria: missing 
information on child weight and length at birth, date of birth, gender, gestational age; and 
maternal characteristics for example age at delivery, calf circumference, height, 
educational level, marital status, parity, breastfeeding duration, and patella lead (N=378 
excluded). Also excluded were low birth weight (<2500 g, N=77) and premature (<37 
weeks of gestation, N=97) neonates in order to minimize bias in the results due to 
postnatal catch-up growth characteristic of these infants (Binkin, Yip et al. 1988). 
Subjects with extreme outliers of child anthropometry (weight and height, N=58), 
maternal anthropometry (calf circumference and height, N=5), and lead measures (tibia 
and patella bone lead, and log-transformed child blood lead, N=34) were excluded from 
further analysis. Because participants could have been excluded for multiple reasons, the 
final analytic sample was comprised of 1000 mothers of 523 males and 477 females. 
 
At time of recruitment, mothers in each cohort were given detailed information 
about the study procedures, provided information on ways to minimize lead exposure and 
signed a written letter of informed consent. The research protocol was approved by the 
Ethics and Research Committees of the partnering institutions including the National 
Institute of Public Health of Mexico, the Harvard School of Public Health, the Brigham 








Participants were interviewed after delivery for all cohorts at the maternity 
hospitals; and at the research clinic when the child was 1, 5, and 7 months of age (cohort 
1) and 3 and 6 months of age (cohorts 2A, 2B, and 3). Study visits were then scheduled at 
age 12 months and every 6 months thereafter until age of 48 months for cohort 1 and 60 
months for the other cohorts. Maternal and child characteristics were collected through 
questionnaires administered by research staff.   
Gestational age was estimated from the date of the last menstrual period recalled 
by the mother. At each study visit, mothers were asked whether they were breastfeeding. 
Because study visits were scheduled at different timepoints for each cohort, breastfeeding 
status was assessed at 7 months for cohort 1 and at 6 months for cohorts 2A, 2B, and 3. 
From here on we will refer to this variable as breastfeeding for 6 months. 
 
 Exposure Assessment 
 
Bone Lead Measurements 
In vivo maternal bone lead measurements (µg lead per/g bone mineral) were taken 
at 1 month of delivery (+/- 5 days) at two bone sites, the mid-tibial shaft (cortical bone) 
and the patella (trabecular bone) using K X-ray fluorescence (K-XRF). Bone lead was 
measured non-invasively using a spot-source 
109
Cd K-XRF instrument constructed at 
Harvard University and installed in a research facility in the American British Cowdray 
Medical Center in Mexico City. The physical principles, technical specifications, and 
 30   
 
validation of this and other similar K-XRF instruments have been described in detail 
elsewhere (Hu, Milder et al. 1989; Burger, Milder et al. 1990; Hu, Milder et al. 1991; 
Aro, Todd et al. 1994; Hu, Aro et al. 1995; Hu, Rabinowitz et al. 1998). When excited 
with a 
109
Cd gamma-ray source, lead atoms in the target tissue emit fluorescent photons. 
This X-ray signal is then analyzed by a computer and provides a bone lead measurement. 
Negative measurements are generated when the true bone lead value is below the limit of 
detection (2 ppb).  
 
Blood Lead Measurements 
Whole blood was collected from children in trace metal-free tubes (BD 
Vacutainer  #367734, Becton-Dickinson, Franklin Lakes, NJ) and sampling was 
conducted at each interview by trained staff using standard protocols. Blood lead samples 
were analyzed at the metals laboratory of the American British Cowdray Hospital in 
Mexico City using a graphite furnace atomic absorption spectroscopy (GFAAS) (Perkin-
Elmer 3000, Chelmsford, MA, USA). The units of measurement are in micrograms per 
deciliter (µg/dL). The instrument precision is within 1 µg/dL and the limit of detection is 
less than 1 µg/dL. Blood lead measures were not collected at every visit due to child or 
maternal refusal, child inability to give blood, child being sick, or not scheduling a blood 
lead measure at that visit. 
 
As described elsewhere (Gonzalez-Cossío, Peterson et al. 1997), external blinded 
quality control samples were analyzed by the Maternal & Child Health Bureau (MCHB) 
and the Wisconsin State Laboratory of Hygiene (WSLH) Cooperative Blood Lead 
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Proficiency Testing Program (PBPTP), and demonstrated adequate precision and 
accuracy determinations at the American British Cowdray Hospital, (r= 0.98; mean 
difference of 0.71 µg/dL compared with MCHB and WSLH PBPTP blanks and spikes). 
 
Statistical analyses  
 
Univariate and Bivariate Analyses 
Descriptive statistics and distributions were examined. Extreme outliers of 
maternal and child anthropometry and lead measures were identified using the 
generalized extreme studentized deviation (ESD) method (Rosner 1983). T-test for 
continuous variables and chi-squared test for categorical variables were carried out to 
compare differences between participants with complete information and participants 
excluded due to the additional study eligibility criteria.  
Covariates were chosen a priori based on biological relevance and were included 
in the analyses as known predictors of child’s weight or potential confounders of the 
association between prenatal lead exposure and child weight over time. These consisted 
of: maternal anthropometry (height and calf circumference), socio-demographic 
characteristics (education, marital status, parity, age at delivery), lifestyle (breastfeeding), 
and child characteristics (such as gestational age, cohort, and repeated measures of child 
height) (Gonzalez-Cossío, Sanín et al. 1998). Maternal socio-demographic characteristics 
such as education and marital status have been correlated with birth outcomes and are 
reflective of available resources and prenatal nutrition (Cogswell and Yip 1995; Kramer, 
Seguin et al. 2000). Young and old maternal age have been associated with low birth 
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weight and other adverse birth outcomes (Kramer 1987). Parity was included in the 
model to account for bone lead mobilization due to previous pregnancies (Hernández-
Avila, Gonzalez-Cossío et al. 1996) and for size at birth (children from primiparous 
women tend to be smaller at birth) (Kramer 1987). Breastfed children have a different 
growth pattern than formula-fed children (Dewey, Heinig et al. 1993; Garza and De Onis 
1999; de Onis, Onyango et al. 2006; de Onis, Garza et al. 2007). In addition, 
breastfeeding is an important covariate as research has demonstrated that lead can be 
excreted into breast milk, exposing the fetus to lead (Ettinger, Téllez-Rojo et al. 2004; 
Ettinger, Téllez-Rojo et al. 2004).  
The correlations among pairs of predictors were examined to assess potential 
multicollinearity. Linear regression models were performed to examine the bivariate 
relationship between each variable and our primary exposure variables (patella and tibia 
bone lead measures).  
 
Outcome Models 
Given the repeated measures of child weight over time, varying coefficient 
models with random effects were used to quantify the multivariable association of child, 
maternal, and lead characteristics with weight over time:  
itiiti tbXtty )()()( 10)(  
The attained weight by child i at age t is denoted by yi(t); β0(t) is the average weight for 
the sample population at time t; β1(t) represents changes to the average weight trajectory 
associated with covariate X; bi(t) is a subject-specific random effect; and εit is the random 
error. The terms β0(t) and β1(t) are time varying coefficients and are smooth functions of 
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child’s age in months. For example, β0(t) evaluated at t=0, β0(0), would be the weight at 
birth for the average individual; similarly, β1(0) would be the average difference in 
weight at birth associated with a 1 unit increase in X. Hence, the model allows the 
association between weight and the covariate X to change with child’s age (i.e., a time-
varying coefficient), and be evaluated at particular times during child’s growth (e.g., at 1 
month after birth). 
Multivariable outcome models were fitted separately for males and females to 
assess the effect of prenatal lead exposure as measured by levels in maternal patella and 
tibia bone on child weight trajectories, adjusted for potential confounders. We define 
“weight trajectories” as the repeated measures of child’s attained weight at each age (in 
months) between birth and 5 years of age. The intercept and child’s age were treated as 
random effects. All other variables were fixed effects and were centered at their mean. 
Models were examined separately for tibia and patella because of collinearity between 
the two bone lead measures; bone lead measures were standardized.  
We constructed the predicted weight trajectories for children 2 standard 
deviations (SD) above and below the sample mean of bone lead by estimating 
)(ˆ2)(ˆ0 tt lead , this can be obtained from model output using the predict 
function in R. Data were analyzed using SAS 9.2 (Cary, NC, SAS Institute Inc.) and R 









Of the 1504 mother-infant pairs, 1000 participants had complete information at 
baseline (290 in cohort 1; 150 in 2A; 300 in 2B; and 260 in 3). There were statistically 
significant differences between those participants included in the analyses and those 
excluded for the following variables: gestational age, weight at birth, marital status, 
breastfed for 6 months, and patella and tibia bone lead (Table II-1). The differences 
observed for gestational age and weight at birth reflected this study’s eligibility criteria of 
excluding premature and low birth weight infants. Bone lead differences were found due 
to the exclusion of outliers from the analytical sample.  
In the pooled analysis, participating mothers had a mean age at delivery of 26 
years. Most mothers were married (70%), had on average 10+ years of education, and 
39% were primiparous. Mean maternal bone lead at 1-month postpartum across all three 
cohorts was 10.4 µg Pb/g (SD= 11.8) for patella and 8.6 µg Pb/g (SD= 9.7) for tibia; the 
correlation was 0.34 (P<0.001) between the two bone lead measures. Bone lead levels 
differed by cohort: 13.6 µg Pb/g (SD= 14.5) for Cohort 1; 12.9 µg Pb/g (SD= 11.1) for 
Cohort 2A; 8.6 µg Pb/g (SD= 9.9) for Cohort 2B; 7.2 µg Pb/g (SD= 9.6) for Cohort 3, 
reflecting declines in environmental lead levels over time; but did not differ appreciably 
by gender (10.2 µg Pb/g (SD= 11.9) for males, 10.7 µg Pb/g (SD= 11.7) for females). 
Children’s mean blood lead level across all ages was 3.9 µg/dL (SD= 3.05). Thirty-one 
percent of children had a blood lead level that exceeded 10 µg/dL at some point in the 
study; but this accounted for only 8% of all blood lead measures.  
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Table II-2 shows the associations between patella lead and other child and 
maternal characteristics. Older mothers had a higher bone lead burden compared to 
younger mothers (β= 0.52, SD= 0.06). Primiparous women had lower patella lead levels 
than multiparous women. Patella bone lead was significantly associated with repeated 
measures of child blood lead up to 48 months.  
 
Figure II-1 depicts the adjusted weight trajectories of children exposed to 2 SD 
above (high exposed) and 2 SD below (low exposed) the maternal patella lead sample 
mean, stratified by gender. Females exposed to high lead levels had a reduced weight 
trajectory compared to females exposed to low lead levels (Figure II-1, Panel A). The 
association between patella lead and weight was not statistically significant until 19 
months of age when the mean weight difference between those exposed to low lead 
compared to those exposed to high lead was -280 g (95% CI= -570 to -3). Between 19 
months and 5 years of age, the association of maternal patella lead with female’s weight 
became significantly larger (see Panel A, P-value for trend <0.1). Among males, the 
difference in weight trajectories was not noticeably different between those exposed to 
low and those exposed to high maternal patella lead levels (Figure II-1, Panel B). Males 
with corresponding high maternal patella lead exposure had a seemingly higher weight 
trajectory, though not significantly different from those exposed to low patella lead, an 
effect opposite to what was observed among females. For example, at 12 months of age, 
the average weight of males exposed to high patella lead was 84.9 g (95% CI= -176.6 to 
346.5) higher than males exposed to low patella lead.  
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Table II-3 gives the unadjusted and adjusted associations between a 1 SD increase 
in patella lead and weight at various ages. After controlling for children’s concurrent 
blood lead levels, the association between patella lead and weight described above 
persisted. The association of patella lead with weight of females was statistically 
significant at 15 months of age when a 1 SD increase in patella lead was associated with 
a -77.2 g decrease in weight (95% CI= -152.8 to -1.5). Among males, a 1 SD increase in 
patella lead was seemingly but not substantially associated with a decrease in 13.6 g by 
48 months of age (95% CI= -97.9 to 70.8). 
In adjusted models, tibia lead was not associated with decreases in weight over 
time among males or females (results not shown). After adjusting for concurrent blood 
lead levels, the association of tibia lead with weight of males or females remained the 
same.  
 
 Figure II-2 illustrates the partial residual plots for the effect of 1 SD increase in 
patella lead on weight at selected ages, adjusted for all covariates, which provide 
evidence that the association between patella lead and weight was linear at each age. 
When child blood lead was added to the model, the association remained linear at every 
age (results not shown). 
 
 We observed no change in the association between patella lead and weight over 
time among females or males when the outliers of patella lead in the analytic sample 
(approximately 4.5 SD above the mean), were included in the model (results not shown). 
Although the mean weight difference between those exposed to low levels of lead and 
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those exposed to high levels was not statistically different, graphically the trajectories 
appeared to be distinct for both females and males (as what was observed in the original 




This is the first longitudinal study to investigate the association of cumulative 
prenatal lead exposure as measured by maternal bone lead levels with child’s weight 
trajectory between birth and 5 years of age. These results extend our previous findings 
(Gonzalez-Cossío, Peterson et al. 1997; Sanín, Gonzalez-Cossío et al. 2001), relating 
prenatal lead exposure with weight decrements at birth and 1-month of age, by examining 
associations with weight up to 5 years. Our results suggest that prenatal lead exposure is 
associated with a sustained decrease in child weight over time among females, but not 
males, independent of postnatal lead exposure and adjusting for several predictors of 
child’s weight and other covariates.  
Cross-sectional studies have investigated the association of child blood lead levels 
with weight (Ignasiak, Sławińska et al. 2006; Little, Spalding et al. 2009). Ignasiak et al. 
observed a 2800 g decrease in weight among males and 3500 g decrease among females 
for each 10 µg/dL increase in blood lead levels among 899 7 to 15 year-old youth in 
Poland (Ignasiak, Sławińska et al. 2006). Mean blood lead level in that study (7.7 µg/dL, 
SD= 3.5) however, was higher than in our study cohort (3.9 µg/dL, SD= 3.05). Little et 
al. found that a 10 µg/dL increase in concurrent child blood lead levels was associated 
with a 1900 g (95% CI= 1700 to 2100) decrease in weight among 360 children 2-12 years 
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of age  in Dallas, Texas (Little, Spalding et al. 2009). Their study population consisted of 
2 cohorts of children recruited 20 years apart. Mean blood lead of the first cohort was 
24.8 µg/dL (SD= 11.0) and of the second cohort was 1.8 µg/dL (SD= 1.8) (Little, 
Spalding et al. 2009). In another longitudinal study, Schell et al. observed a decrease in 
weight-for-age z-score at 6 (-0.77, SE=0.34) but not 12 months of age associated with 
maternal second trimester blood lead level higher than the median (≥ 3 µg/dL) (Schell, 
Denham et al. 2009).  
Fetal lead exposure may exert its effects on growth through effects on bone mass 
(which is related to weight). Campbell and colleagues observed that children with high 
blood lead levels (≥ 15 μg/dL) had higher bone densities than those with low blood lead 
levels (<15 μg/dL) - suggesting that lead may inhibit proteins involved in the growth of 
chondrocytes, thereby causing premature maturation of the chondrocytes, which may 
have resulted in higher bone densities among lead-exposed children (Campbell, Rosier et 
al. 2004). In our study, in contrast, we found that higher lead exposure was associated 
with decreased weight. Fetal lead exposure may also exert its effect on growth through 
disruption of thyroid signaling. Specifically, a lead-induced deficiency in maternal 
thyroid hormone (hypothyroidism) might limit the amount of thyroid hormone available 
to the fetus (Zoeller, Dowling et al. 2002) thus decreasing soft tissue and organ growth 
(Glinoer 1997; Hernández-Avila, Peterson et al. 2002). An epidemiological study in 
Kosovo found that maternal blood lead was negatively associated with maternal free 
thyroxine (FT4) among mothers with high blood lead levels (mean= 20.56 µg/dL, SD= 
7.38) but not among those with lower blood lead levels (mean= 5.60 µg/dL; SD= 1.99). 
The authors also found an association between prenatal exposure to maternal FT4 and a 




 increase in the rate of change of BMI between birth and 1 year of age (95% 
CI= 0.11 to 0.48) (Lamb, Janevic et al. 2008). 
We did not find an association of tibia lead with weight of males or females. This 
might be due to the fact that lead accumulates slower in the cortical bone (tibia) than in 
the trabercular bone (patella). Trabercular bone is more vascularized, and thus reflects 
more recent lead exposure than cortical bone (Hu, Milder et al. 1989; Hu, Rabinowitz et 
al. 1998).   
In adjusted models, maternal tibia lead was not associated with decreases in 
weight over time among females (results not shown). Among males, a 1 SD increase in 
tibia was noticeably related to an 82.2 g increase in weight at 36 months (95% CI= 8.2 to 
156.1) and thereon. After adjusting for concurrent blood lead levels, the effect of tibia 
lead on weight of males was not significant. 
 
We found differences in associations by gender. Cross-sectional lead levels have 
been associated with decreases in weight and BMI among females but not males between 
7 and 14 years of age (Ignasiak, Sławińska et al. 2006). That study’s authors suggested 
that the BMI result might have occurred because lead was more strongly related to 
females’ than males’ height. Among children, height is moderately correlated with BMI 
(Freedman and Sherry 2009), unlike among adults. Lead might disrupt the endocrine 
system’s functions differently among males and females. The effect of lead on growth 
might be mediated by its impact on estrogen metabolism. Estrogen stimulates growth 
hormone secretion, which in turn leads to increased levels of IGF-1 and body growth 
(Juul 2001; Leung, Johannsson et al. 2004). Prenatal lead exposure has been 
 40   
 
demonstrated to decrease levels of estradiol (Dearth, Hiney et al. 2002; Iavicoli, Carelli et 
al. 2004) and IGF-1 (Ronis, Badger et al. 1998) in female rats and mice. The suppression 
of estrogen by lead might cause low levels of growth hormone, and IGF-1 thus reduced 
weight gain in females.   
 
The decrease in bone lead levels in our later cohorts reveals the reduction in 
environmental lead exposure particularly due to phasing out of leaded gasoline in Mexico 
in the mid-1990s (Romieu, Palazuelos et al. 1994). Bone lead levels in this study were 
comparable to those of a cohort of 700 women in Los Angeles in the mid to late 1990s 
where mean calcaneus lead (a measure of trabecular bone lead) was 10.7 g Pb/g (SD= 
11.9) and tibia bone lead was 8.0 g Pb/g (SD= 11.4) (Rothenberg, Kondrashov et al. 
2002). Bone lead levels in our study were, however, lower compared to a cohort of 
residents in Southern Ontario, in which tibia lead levels among women ages 15 to 40 
were around 5 g Pb/g (Roy, Gordon et al. 1997) and among a cohort of women who had 
recently delivered in Boston in the late 1980s (mean patella lead level was 5 g Pb/g) 
(Hu, Hashimoto et al. 1996). Children’s blood lead levels in our pooled analysis were 
higher than mean levels among 1 to 5 year olds in the U.S. between 1999 and 2008 (EPA 
2009).  
We found that primiparous mothers had lower patella lead levels than multiparous 
women. This association was likely confounded by maternal age. In fact, when including 
maternal age in the model, the association of maternal patella lead with parity became 
non-significant. 
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Our study has several potential limitations. We did not consider the potential 
effect of other environmental pollutants on growth and their interaction with lead. Also, 
we did not account for adequacy of maternal or child dietary intake. However, despite 
these limitations, we believe our results are still valid given the longitudinal design of our 
study, the adjustment for several predictors and potential confounders, and the use of 
bone lead as a measure of cumulative prenatal lead exposure. Moreover, our results are 
generalizable to mother-children pairs as mothers in our study population comprised a 




Prenatal lead exposure reflected by maternal patella lead is associated with a 
lower weight trajectory among 0 to 5 year old female but not male offspring. These 
results indicate that the impact of fetal lead exposure on growth can persist for years, 
even after adjusting for postnatal lead exposure. Future research might investigate 
whether those effects persist into early adolescence.
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Male (%) 52.3 502 48.4
Gestational age (months) 39.2 1.1 429 38.0 2.1 **





Birth weight (kg) 3.2 0.4 432 3.0 0.6 **
Maternal Characteristics
Age at delivery (years) 25.7 5.3 436 25.6 5.4
Calf circumference (cm) 34.1 3.0 361 34.4 3.8
Height (cm) 154.6 5.7 421 154.0 6.1
Marital status 433 **
Married 70.7 68.4
With partner 21.8 19.6
Single, separated, or divorced 7.5 12.0
Education (years) 10.5 3.2 437 10.2 3.1
Parity 438
Primiparous 38.7 40.0
1 previous child 34.4 34.0
2+ previous children 26.9 26.0
Smoked during pregnancy (%) 4.5 434 3.7
Breastfed for 6 months (%) 68.1 501 61.3 **
Lead biomarkers 
Child blood lead (µg/dL) 3.8 2.9 347 3.8 3.0
Patella (µg Pb/g) 10.4 11.8 258 12.9 15.9 **
Tibia (µg Pb/g) 8.7 9.7 254 10.2 11.8 **
Significance level: ** <0.05
‡ N=1000 except for tibia (N=846), and children's mean blood lead level 
across all ages (N=673).
¶ The sample population consists of the combination of three 
sequentially-enrolled longitudinal pooled birth cohorts 
Included ‡ Excluded
 43   
 











2B -4.97 0.95 **
3 -6.44 0.98 **
Maternal characteristics
Age at delivery (years) 0.52 0.06 **
Calf circumference (cm) -0.03 0.12
Height (cm) -0.11 0.06
Marital status
Married Referent
With partner -0.5 0.91
Single, separated, or divorced -2.79 1.43
Education (years) 0.01 0.11
Parity 
Primiparous Referent
1 previous child 2.58 0.87 **
2+ previous children 4.32 0.93 **
Breastfed for 6 months 0.53 0.80
Calcium treatment during lactation 4.56 1.05 **
Calcium treatment during pregnancy -5.1 1.08 **
Lead biomarkers
Repeated measures of child blood lead (µg/dL) ‡
12 months 0.50 0.12 **
24 months 0.39 0.10 **
36 months 0.39 0.12 **
48 months 0.54 0.14 **
60 months 0.29 0.22
Tibia (µg Pb/g) 0.42 0.03 **
Significance: ** <0.05
‡ Here we report the yearly blood lead measures at visits common to all 3 
cohorts (except cohort 1 when last study visit was 48 months).  
 
 
Table II-3: Associations between 1 standard deviation increase in maternal patella lead and weight of females and males at 
different ages 
Females
Birth -45.2 -145.6 , 55.2 -45.2 -122.8 , 32.3 -45.7 -131.7 , 40.2
12 -57.5 -152.8 , 37.7 -62.4 -134.5 , 9.7 -70.9 -147.9 , 6.0
24 -69.9 -164.3 , 24.6 -79.5 -151.1 , -8.0 -96.1 -170.4 , -21.8
36 -82.2 -180.4 , 16.0 -96.6 -172.6 , -20.6 -121.3 -200.0 , -42.6
48 -94.5 -200.4 , 11.4 -113.8 -198.5 , -29.1 -146.4 -235.5 , -57.4
60 -106.8 -223.6 , 10.0 -130.9 -227.4 , -34.4 -171.6 -275.2 , -68.0
Males
Birth 27.2 -60.1 , 114.5 22.5 -47.5 , 92.6 72.3 -9.8 , 154.4
12 16.2 -66.4 , 98.8 20.6 -44.7 , 86.1 29.4 -42.1 , 100.8
24 5.2 -76.9 , 87.2 18.7 -46.2 , 83.7 27.8 -43.5 , 99.1
36 -5.8 -91.6 , 80.0 16.9 -52.0 , 85.8 7.9 -67.3 , 83.1
48 -16.8 -110.1 , 76.5 14.9 -61.5 , 91.5 -13.6 -97.9 , 70.8
60 -27.8 -131.6 , 76.0 13.0 -73.7 , 99.9 -35.0 -132.4 , 62.3
¶ Additionally adjusted for repeated measures of concurrent child blood lead.
95%CI β 95%CI
‡ Adjusted for cohort, maternal age at delivery, calf circumference, height, education, number of 
pregnancies, breastfeeding for 6 months, child’s gestational age at birth and height.
Unadjusted Adjusted ‡ Fully adjusted ¶
Age 
(months)
The effect estimates represent the association of 1 standard deviation increase in maternal patella 









Figure II-1: Adjusted weight trajectory of children exposed to 2 standard deviations of patella lead above and below the mean 
  
The dashed curve represents the average weight growth of children exposed to 2 standard deviations of maternal patella lead 
below the mean. The straight curve represents the average weight growth of children exposed to 2 standard deviations of 
maternal patella lead above the mean.  
The weight trajectories are adjusted for cohort, maternal age at delivery, calf circumference, height, education, number of 
pregnancies, breastfeeding for 6 months, and child’s gestational age at birth and height. 







    
 
Figure II-2: Weight-patella association at various ages 
  
These figures represent partial residual plots of weight and patella lead at each age. The different symbols reflect the data 
points at each age: triangles correspond to 60 months, kites to 24 months, and circles to 12 months. 
For females, 1 standard deviation increase in maternal patella lead was associated with a weight decrease of 62.4 g (SD= 36.8) 
at 12 months; 79.5 g (SD= 36.5) at 24 months; 113.8 g (SD= 43.2) at 48 months; and 130.9 g (SD= 49.2) at 60 months. This 
decrease was statistically significant at 19 months. 
For males, 1 standard deviation increase in maternal patella lead was associated with a weight increase of 20.6 g at 12 months; 
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Early-life environmental lead exposure has been shown to have long-term health 
impacts on growth and development, but relatively few studies have examined lead’s 
specific effects on height and BMI during potentially susceptible periods. Some research 
suggests that lead has an adverse effect on height (shorter) and BMI (greater) that is both 
exposure-and time-dependent and that may be wholly or partially reversible. However no 
study has examined the longitudinal association of pre- and post-natal lead exposure 
during susceptible periods on height and BMI at ages later than 33 months. 
 
Methods: 
The sample population consists of longitudinal pooled birth cohorts recruited 
between 1994 and 2005 in Mexico City. Lead exposure history categories were 
constructed based on exposure during the prenatal period (measured by maternal patella 
lead assessed at 1-month postpartum using in vivo K-X-ray fluorescence), infancy 
(average child’s blood lead between birth to 24 months), and childhood (average child’s 
blood lead between 30 and 48 months). Linear regression models adjusted for important 
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Children with higher lead exposure during mother's pregnancy attained a mean 
height that was somewhat shorter at 48 months (-0.32 cm, 95% CI= -0.90 to 0.25) than 
children with lower levels, regardless of post-natal exposure and adjusting for covariates. 
Children with high blood lead levels during infancy (birth to 24 months) attained a mean 
height at 48 months that was significantly shorter and with a greater effect size (-1.00 cm, 
95% CI= -1.59 to -0.40, significant) than children with lower levels. Children with high 
blood lead levels during early childhood (30 to 48 months), on the other hand, were 
somewhat taller than their counterparts (0.50 cm, 95% CI = -0.08 to 1.09). This result 
was not significant, however. 
 
Conclusion: 
Our study suggests that early life lead exposure has a negative impact on skeletal 
growth that remains evident at 48 months of age, with an exposure window of greatest 





Early life influences on development have been shown to have long-term health 
outcomes (Barker 2004). One such environmental influence is lead. Several studies have 
related lead exposure to childhood deficits in height (Schwartz, Angle et al. 1986; Shukla, 
Bornschein et al. 1989; Little, Snell et al. 1990; Frisancho and Ryan 1991; Shukla, 
Dietrich et al. 1991; Ballew, Khan et al. 1999; Hernández-Avila, Peterson et al. 2002; 
Ignasiak, Sławińska et al. 2006; Lamb, Janevic et al. 2008; Little, Spalding et al. 2009) 
and body mass index (BMI) (Ignasiak, Sławińska et al. 2006; Little, Spalding et al. 2009; 
Schell, Denham et al. 2009). Other studies did not find an association between lead 
exposure and BMI (Ballew, Khan et al. 1999), while other studies observed a higher BMI 
among lead-exposed children (Kim, Hu et al. 1995; Lamb, Janevic et al. 2008). 
The effect of environmental influences such as lead on growth is not constant over 
time, and would be better defined through an exposure-time framework identifying 
sensitive periods. Sensitive windows of physical development have been portrayed as 
periods where exposure to environmental influences most detrimentally affects 
development later on (Tanner 1990; Lemasters, Perreault et al. 2000; Ben-Shlomo and 
Kuh 2002). Sensitive windows of exposure have been described in the literature of 
lifecourse epidemiology and developmental origins of adult disease (Lemasters, Perreault 
et al. 2000; Ben-Shlomo and Kuh 2002; Barker 2004): prenatal (from conception to 
birth), infancy (between birth and 24 months), and early childhood (after 24 months). 
During sensitive time periods, the developing system is highly susceptible to 
environmental insults given that developmental changes are occurring rapidly due to 
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increased cellular proliferation (Ben-Shlomo and Kuh 2002; Morford, Henck et al. 2004; 
Louis, Cooney et al. 2008).  
In terms of exposure, infants aged 0 to 24 months and children between 24 to 48 
months have different gastrointestinal absorptions of lead, respiratory ventilation rate, 
and proximity to the ground (EPA 1997; Selevan, Kimmel et al. 2000). Thus, younger 
children may have an increased lead exposure and dose. 
Epidemiologic studies have suggested that the effect of lead may be wholly or 
partially reversible: early high lead exposure has been associated with decrements in 
attained length at 15 months (Shukla, Bornschein et al. 1989) but attenuation of exposure 
at later ages resulted in catch-up growth 33 months (Shukla, Dietrich et al. 1991). 
Another study observed a catch-up growth at 12 months (Schell, Denham et al. 2009) 
following early high lead exposure. 
These results, however, are limited in terms of ages followed and lead exposure 
measures. Maternal bone lead concentration is a better biomarker of the cumulative 
maternal lead burden than is maternal blood lead during pregnancy (Hu 1998).  
In the present study, we investigated the association of prenatal, infancy, and 
childhood lead exposure – different sensitive time windows – on attained height and BMI 












Similar exclusion criteria were applied to the three cohorts (Gonzalez-Cossío, 
Peterson et al. 1997; Téllez-Rojo, Hernández-Avila et al. 2002; Hernández-Avila, 
Gonzalez-Cossío et al. 2003). Additional eligibility criteria were applied for this study. 
Out of 1253 participants who showed up at the 48 months visit, 157 did not have a height 
measure obtained, and 185 were excluded due to missing information on the following 
variables: child weight and length at birth, gender, gestational age; and mother’s age at 
delivery, calf circumference, height, educational level, marital status, parity, breastfeeding 
duration, and patella lead. Extreme outliers of child (weight and length at birth; weight 
and stature at 48 months, N=25) and maternal anthropometry (height and calf 
circumference, N=5) were identified. Subjects with outliers (maternal patella bone lead, 
N=6; and log-transformed child blood lead, N=173), or missing (23) lead measures were 
excluded. Also excluded were low birth weight (<2500 g, N=61) and premature neonates 
(<37 weeks of gestation, N=48), in order to minimize bias in the results due to postnatal 
catch-up characteristic of these infants (Barker, Osmond et al. 2005). Participants could 
have been excluded for multiple reasons, thus the final sample size consisted of 756 





The research protocol was approved by the Ethics and Research Committees of 
the partnering institutions including the National Institute of Public Health of Mexico, the 
Harvard School of Public Health, the Brigham and Women’s Hospital, the University of 




Bone Lead Measurements 
Maternal bone lead was assessed at approximately 1-month postpartum using in 
vivo K-X-ray fluorescence (K-XRF). Measures were taken at the mid-tibial shaft (cortical 
bone) and the patella (trabecular bone). The instrument and validation have been 
extensively described (Burger, Milder et al. 1990; Hu, Milder et al. 1991; Aro, Todd et al. 
1994; Hu, Aro et al. 1995). Analyses were conducted for maternal patella lead due to a 
smaller sample size of tibia measurements. 
 
Blood Lead Measurements 
Child blood was collected in trace metal-free tubes (BD Vacutainer  #367734, 
Becton-Dickinson, Franklin Lakes, NJ) between birth and 4 years of age and lead 
concentrations were measured using a graphite furnace atomic absorption spectroscopy 
(GFAAS) (Perkin-Elmer 3000, Chelmsford, MA, USA) at the metals laboratory of the 
American British Cowdray Hospital in Mexico City. External blinded quality control 
samples were analyzed by the Maternal & Child Health Bureau (MCHB) and the 
Wisconsin State Laboratory of Hygiene (WSLH) Cooperative Blood Lead Proficiency 
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Testing Program (PBPTP), as described elsewhere (Gonzalez-Cossío, Peterson et al. 
1997). 
 
Lead exposure history 
To address the question of windows of vulnerability we created eight lead 
exposure history categories based on three windows during development: prenatal lead 
exposure (maternal patella lead); infancy lead exposure (average blood lead between 
birth and 24 months of age); early childhood lead exposure (average blood lead between 
30 and 48 months of age). At each period, a child was classified as having high or low 
lead exposure defined by the median lead level at each period. Denoting H and L as high 
and low during each period (for example HHH = high prenatal, high infancy, high 
childhood), we created the following exposure categories for height: group 1 (HHH, 
n=156), group 2 (HHL, n=60), group 3 (HLH, n=51), group 4 (HLL, n=111), group 5 
(LHH, n=112), group 6 (LHL, n=52),  group 7 (LLH, n=60), and group 8 (LLL, n=155). 
Due to a smaller sample size, the number of participants in each lead exposure category 





Hypotheses and Power analyses 
Our primary hypotheses of interest were: a) Prenatal lead exposure detrimentally 
affects child height and BMI at 48 months regardless of postnatal lead exposure; i.e. 
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children in the combined categories 1 to 4 will have lower height and BMI than children 
in the combined categories 5 to 8. b) Similarly, children exposed to high lead levels 
during infancy (categories 1, 2, 5, and 6) will have lower attained height and BMI than 
children exposed to low levels (categories 3, 4, 7, and 8). c) Children exposed to high 
lead levels during early childhood (groups 1, 3, 5, and 7) will have lower attained height 
and BMI than children exposed to low levels (groups 2, 4, 6, and 8). We also selected 
secondary hypotheses to explore differences between exposure subgroups (Table III-2). 
The power to detect a 1 cm difference ranged from 73% to 97%; and that of a 0.5 kg/m
2 
difference from 84% to 99% across hypotheses. 
 
Descriptive and bivariate analyses 
 Distributions were examined prior to statistical analyses. Extreme outliers of 
maternal and child anthropometry and lead measures were identified using the 
generalized extreme studentized deviation (ESD) method (Rosner 1983). Differences 
between participants with complete information and participants excluded due to the 
additional study eligibility criteria were compared using T-test for continuous variables 
and chi-squared test for categorical variables.   
 
Group contrasts 
We estimated linear regression models with exposure history groups coded as 
indicator variables. All models were adjusted for maternal height and calf circumference, 
number of previous pregnancies, marital status, education level, breastfeeding for 6 
months, cohort, calcium treatment during lactation and pregnancy, age at delivery, and 
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gestational age. Height models were adjusted for birth length and BMI models for birth 
weight. Covariates were chosen based on biological relevance. From the adjusted models, 
we employed contrasts to compare the groups of lead exposure categories depicted by the 




Socio-demographic and other characteristics of the sample population (N=756) 
are presented in Table III-1. Median maternal patella bone lead was 10.4 µg Pb/g (SD= 
11.6). Median infancy child blood lead was 5.3 µg/dL (SD= 2.8); median blood lead 
during early childhood 6.3 µg/dL (SD= 2.9) (Table III-1). Certain characteristics differed 
between included and excluded participants. These differences were mainly due to the 
additional eligibility criteria of excluding low birth weight and premature infants, and to 
the outliers of anthropometry and lead measures. Another difference noted was in 
maternal educational level. 
  
Figures III-1A and III-1B show the adjusted attained height and BMI at 48 
months, respectively, by lead history categories. Children with the highest attained height 
were in group LLH; the lowest attained height in group LHL. Children with the highest 
attained BMI were in groups HLH and LLH whereas children with the lowest BMI were 
in HHL and LLL. 
 Table III-2 shows the unadjusted and adjusted results of hypothesis testing using 
general linear models. Children exposed to high levels of lead during pregnancy were not 
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significantly shorter at 48 months (β= 0.32, 95% CI= -0.90 to 0.25) than children exposed 
to lower levels, regardless of postnatal exposure and adjusting for covariates. Children 
exposed to high levels of lead during infancy (birth to 24 months) were 1 cm (95% CI= -
1.59 to -0.40) shorter at 48 months than children exposed to low levels in adjusted 
models. In contrast, children exposed to high levels of lead during early childhood (30 to 
48 months) were not significantly shorter at 48 months than children exposed to low 
levels (β= 0.50, 95% CI= -0.08 to 1.09), regardless of prior lead exposure. 
Our secondary hypotheses consisted of comparing pairs or combinations of 
groups based on the general hypothesis that higher lead exposure earlier would lead to 
growth deficits. We found that children with consistently high levels of lead exposure 
(group 1, HHH) were 0.98 cm (95% CI= -1.87 to -0.10) shorter than children with 
consistently low levels of lead exposure throughout preschool years (group 8, LLL) 
(Table III-2). Children in group 1 (HHH) were marginally significantly shorter by 0.64 
cm (95% CI= -1.33 to 0.05) than all other children in our study population. Similarly, 
children in group 8 (LLL) were notably taller compared to all other children. Exposure to 
high levels of lead during infancy (children in groups 1, HHH and 2, HHL) was 
significantly associated with a 1.32 cm (95% CI= -2.12 to -0.52) decrease in attained 
height at 48 months compared to exposure to low levels of lead (children in groups 7, 
LLH and 8, LLL).   
 
 Results for attained BMI at 48 months were in general in the same direction as for 
height. However, none of the groups compared were notably different (Table III-2). For 
example, children exposed to high levels of lead prenatally had a non-significant smaller 
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attained BMI at 48 months compared with children exposed to low levels of lead 
prenatally (-0.03 kg/m
2




We found that children who had been exposed to high levels of lead in infancy 
were shorter at 48 months than children exposed to lower levels. This may reflect that 
bone growth in children is most sensitive to lead exposure during those periods of 
development. High prenatal lead levels were not associated with deficits in height as 
compared to low prenatal levels. Exposure to lead during early childhood was also not 
associated with a lower attained height at 48 months. 
The results of this study are consistent with the literature, where a 2 cm decreased 
length at 15 months was attributable to a 10 µg/dL increase in 3 to 15 months blood lead 
levels and a high maternal blood lead during pregnancy (≥7 µg/dL) (Shukla, Bornschein 
et al. 1989). In a follow-up study, the effect of prenatal lead was supplanted by infancy 
lead levels: children with high early infancy lead levels followed by low early childhood 
lead levels (regardless of prenatal exposure levels), had the highest attained height at 33 
months; providing evidence of catch-up growth (Shukla, Dietrich et al. 1991). In another 
study, Schell and colleagues found that infants exposed to high levels of lead in utero (≥ 3 
µg/dL) followed by high postnatal lead levels (≥ 6 µg/dL) had lower attained length-for-
age (not significantly different), weight, arm and head circumference-for-age at 12 
months (significantly different) than infants in all other exposure groups (Schell, Denham 
et al. 2009). On the other hand, infants exposed to high levels in utero followed by low 
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postnatal lead levels had higher anthropometric indexes at 12 months than any other 
exposure group (not significant for length-for-age); for example a 0.6 higher weight-for-
age z-score than infants exposed to continuous high levels of lead (Schell, Denham et al. 
2009).  
Depending on where children are on the reference growth chart, a 1 cm decrement 
in height at 48 months could have different implications. For example, as compared to 
boys on the 50
th
 percentile-for-age, a 1 cm height decrement could place them 
approximately at the 40
th
 percentile-for-age (WHO Multicentre Growth Reference Study 
Group, 2006). As compared to girls aged 48 months in the 25
th
 percentile-for-age, a 1 cm 
decrement in height could correspond to approximately the 17
th
 percentile, which may 
entail considerable public health implications (WHO Multicentre Growth Reference 
Study Group, 2006). 
The highest attained height was observed among children in the LLH and not the 
LLL group as would have been expected. Similarly, the lowest attained height was found 
among the LHL group and not the HHH group. Given the detrimental impact of lead on 
growth, the average difference in height between the HHH and LLL groups of 0.98 cm 
seems modest. On the other hand, Shukla and colleagues (1991) found a similar result 
where the average difference in height between the two extreme exposure groups was 
0.99 cm (although they defined slightly different lead exposure time windows) (Shukla, 
Dietrich et al. 1991). Differences in our study may also have been attenuated by the error 




We did not observe any effect of lead exposure history on BMI at 48 months. It is 
not known whether lead exposure affects child adiposity. However, as mentioned above, 
lead has been inconsistently associated with BMI, with some studies reporting BMI 
deficits (Ignasiak, Sławińska et al. 2006; Little, Spalding et al. 2009), other reporting 
increases in BMI (Kim, Hu et al. 1995; Lamb, Janevic et al. 2008). However, these 
studies have been limited by their cross-sectional design and lack of chronic exposure 
biomarkers (blood lead vs. bone lead). To further investigate this issue, we conducted 
exploratory analyses. Using the WHO growth standards, we calculated the proportion of 
overweight (≥ 85th percentile and < 95th percentile-for-age, 10.8%) and obese (≥ 95th 
percentile, 5.4%) children at 48 months in each lead history category. The highest 
proportion of overweight and obese children was found in group LHH; the lowest 
proportion in group HHL. Due to a small sample size, we did not have the power to 
detect if the lead exposure categories were associated with the proportion of overweight 
and obese (the power ranged between 0.05 and 0.12). 
 
Although height and BMI measure different aspects of growth (WHO 1995) and 
the effect of lead might occur through different mechanisms, sensitive periods are likely 
to be the same for both outcomes given that the sensitive periods defined are wide in age 
range and that exposure and absorbed dose considerably change between those periods. 
For example, the gastrointestinal absorption of lead for infants aged 0 to 2 years is 
between 42 and 53%, but lower for children 2 to 6 years old (between 30 and 40%) 




Lead is thought to affect bone growth by impairing bone activity (osteoblasts) 
and/or bone cartilage by influencing epiphyseal growth plate chondrocytes (Ignasiak, 
Sławińska et al. 2006). Fetal osteoblasts are bone forming cells involved in the synthesis 
of type I collagen as well as alkaline phosphatase. Animal studies have shown that lead 
impairs osteblast function by reducing osteoblast activity.  Klein and Wiren observed a 
“dose-dependent inhibition” of alkaline phosphatase (important for mineral deposition), 
an enzymatic marker for osteoblast activity among rats (Klein and Wiren 1993). Puzas 
and colleagues recognized that lead alters the process of bone elongation by affecting 
chondrocytes (Puzas, Sickel et al. 1992). In fact, lead alters the signaling pathway of 
chondrocytes by affecting growth factors essential for chondrocytes maturation and 
regulation (Zuscik, Pateder et al. 2002). Zuscik et al. observed that lead alters the normal 
effects of chondrocytes terminal differentiation by acting on the transforming growth 
factor-beta1 (TGF-β1) and other signaling pathways in chondrocytes (Zuscik, Pateder et 
al. 2002). 
 
An objective of this study was to disentangle the effect of lead at each period. The 
different lead measures, however, were partially correlated, which was not surprising. 
Maternal patella lead was somewhat correlated with infancy blood lead (r= 0.19, P<0.05) 
and with early childhood blood lead (r= 0.16, P<0.05). Infancy and early childhood 
blood lead were moderately correlated (r= 0.50, P<0.05). We were thus able to more 
definitively disentangle prenatal vs. postnatal lead exposure more than infancy vs. early 




A relatively high number of subjects were excluded from the analytical sample 
(Table III-1) mainly due to missing demographic, anthropometric, and child exposure 
data. We do not suspect that selection bias could have resulted in an artifactual result 
given that the sample of included and excluded participants differed mainly due to 
exclusion of outliers and that maternal characteristics were comparable. These results are 
representative to Mexican children of low-to-moderate income reproductive-aged 
mothers. An alternative explanation for the results obtained could be that children’s blood 
lead levels peak around 24 months (Bellinger 2004). However, in our study, the mean 
blood lead level of children from birth to 24 months was lower than from 30 to 48 
months. 
 
The analytical approach employed has some limitations. This method of 
averaging exposure during a time window assumes that exposure is constant over this 
specific period. However, two children who have similar blood lead during a specific 
period have not necessarily been exposed to the same concentration of lead. For example, 
we take the case of two children with the same average blood lead of 7 µg/dL between 
birth and 24 months. The first child with two blood lead measures of 4 µg/dL at 6 months 
and 10 µg/dL at 12 months. The second with constant blood lead of 7 µg/dL at two visits. 
The first child who experiences the peak in blood lead might experience a different effect 
on growth than a child with a relatively high, yet constant exposure. While exposure 
changes during each time window, our method assumes it is constant. However, this 
method is able to disentangle the effect of lead at each period defined largely. More 
refined periods would mean an increased number of lead exposure history but a smaller 
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sample size in each group, which could limit inferences. Also, this method has been 
previously used in the literature (Shukla, Dietrich et al. 1991; Schell, Denham et al. 
2009). 
 
Alternative approaches for investigating the effects of time-changing exposure 
have been proposed. For example, several methods in the life course literature (social 
epidemiology) and occupational exposure literature, among others, have been described. 
Some of the methods include analysis of risk accumulation, pathways, and estimating 
latency effects (Richardson 2009). Hallqvist and colleagues (2004) provide a review of 
the first two, as well as the critical periods approach we employed. The first method, risk 
accumulation, considers that the total duration and intensity of specific exposures leads to 
accrued disease risk later in life (Hallqvist, Lynch et al. 2004). The pathway approach 
proposes that changes in exposure throughout the life course might be an important 
predictor of health (Hallqvist, Lynch et al. 2004). Latency estimation refers to calculating 
the time between when the exposure occurred and when the health effect is observed. 
These three methods are interrelated, as they each provide information about timing of 
vulnerability. We chose the critical periods approach as it is most well suited to answering 




Our study suggests that early life lead exposure has a negative impact on skeletal 
growth that remains evident at 48 months of age, with an exposure window of greatest 
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sensitivity occurring in infancy (birth to 24 months). Prenatal lead exposure is not 
associated with height at 48 months as originally hypothesized. In addition, none of the 




Table III-1: Comparison of included and excluded participants 
Mean 




Male (%) 52.0 495 48.5
Gestational age (months) 39.2 1.1 471 38.4 2.1 **
Birth length (cm) 50.4 1.9 456 49.7 3.3 **
Birth weight (kg) 3.2 0.4 470 3.1 0.5 **
BMI at 48 months (kg/m
2
) 15.9 1.5 340 16.2 2.9 **







Age at delivery (years) 25.7 5.3 472 25.3 5.3
Calf circumference (cm) 34.2 3.0 407 34.2 3.6
Height (cm) 154.5 5.5 456 153.8 6.3
Marital status 469
Married 71.2 67.4
With partner 20.6 23.5
Single, separated, or divorced 8.2 9.2
Education (years) 10.5 3.1 473 9.9 3.0 *
Parity 473
Primiparous 39.0 37.2
1 previous child 35.1 33.0
2+ previous children 25.9 24.9
Breastfed for 6 months (%) 68.3 497 67.0
Lead biomarkers 
Mean Child blood lead (µg/dL) from 
birth to 24 months 5.3 2.8 473 5.6 3.2 **
Mean Child blood lead (µg/dL) from 
30 to 48 months 6.3 2.9 379 6.8 3.9 **
Patella (µg Pb/g) 10.4 11.6 327 13.3 15.9 **
Tibia (µg Pb/g) 8.7 9.8 325 10.5 11.1 **
Significance level: ** <0.05
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Lead Exposure History (XYZ) 
X=prenatal; Y=infancy (birth to 24 months); Z=early childhood (30 to 48 months)
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X=prenatal; Y=infancy (birth to 24 months); Z=early childhood (30 to 48 months)







Table III-2: Hypotheses and estimates for height and BMI differences at 48 months 
Hypothesis β β β β
Primary hypotheses
High vs. low prenatal -0.37 -0.96 , 0.21 -0.32 -0.90 , 0.25 -0.08 -0.32 , 0.17 -0.03 -0.27 , 0.21
High vs. low infancy -1.34 -1.93 , -0.76 -1.00 -1.59 , -0.40 -0.05 -0.29 , 0.19 -0.07 -0.32 , 0.18
High vs. low early childhood 0.47 -0.12 , 1.05 0.50 -0.08 , 1.09 0.08 -0.16 , 0.32 0.11 -0.14 , 0.35
Secondary Hypotheses
Group HHH vs. LLL -1.39 -2.22 , -0.57 -0.98 -1.87 , -0.10 -0.03 -0.37 , 0.31 0.03 -0.34 , 0.41
Group HHH vs. all others -0.86 -1.53 , -0.19 -0.64 -1.33 , 0.05 -0.02 -0.29 , 0.26 -0.05 -0.34 , 0.24
Group LLL vs. all others 0.73 0.06 , 1.40 0.49 -0.18 , 1.16 0.02 -0.26 , 0.30 -0.09 -0.37 , 0.19
Groups HHH+HHL vs. LLH+LLL -1.72 -2.50 , -0.93 -1.32 -2.12 , -0.52 -0.12 -0.45 , 0.20 -0.10 -0.44 , 0.23
† Additionnally adjusted for child length at birth 
Estimates for height differences (cm) Estimates for BMI differences (kg/m
2
)
Unadjusted Adjusted ‡ † Unadjusted Adjusted ‡ ¶
¶ Additionnally adjusted for child weight at birth.
95% CI 95% CI 95% CI 95%CI
N=756 for height models, and N=752 for BMI models
‡ Adjusted for maternal age at delivery, parity, marital status, education, breastfeeding, calcium treatment group, cohort, calf 
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Lead exposure during adolescence has been associated with delays in the onset of 
puberty. No study has examined the association of maternal bone lead as a marker of 
prenatal cumulative lead dose with puberty onset. This report describes the prospective 
epidemiological study design used to examine these associations and preliminary findings 
among in a subsample of 43 girls and 31 boys aged 6.5 to 15.5 years.  
 
Methods: 
Maternal bone lead was assessed at 1-month postpartum using in vivo K-X-ray 
fluorescence (K-XRF). Multivariable logistic regression was used to investigate the 
association of prenatal lead exposure with onset of puberty as assessed by self-reported 
Tanner stage greater or equal than 2 for genitalia (among boys), breast (among girls) and 
pubic hair development (for both genders), adjusting for child’s age.  
 
Results: 
Among girls, mean age at study visit was 8.9 years (SD= 1.9); 38% were at stage 
B2 or above and 19% at stage P2 or above. Mean age at menarche was 10.3 years (SD=
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1.5). Among boys, mean age was 9.7 years (SD= 2.5); 59% were at stage G2 or above, 
and 17% at stage P2 or above. For each 1 µg Pb/g increase in maternal patella lead, boys 
had a non statistically significant reduced odds of having entered stage P2 (OR= 0.94, 
95% CI = 0.68, 1.30). The direction of associations was opposite for boys’ genitalia, and 
for girls’ breast and pubic hair development but also statistically non significant.  
 
Conclusion: 
These preliminary results suggest that prenatal lead exposure is not associated 
with pubertal onset in a longitudinal cohort study in Mexico, but interpretation is limited 
by small sample size. Future research in a larger sample from this cohort will further 








Environmental exposures may affect the timing and progression of puberty 
(Ouyang, Perry et al. 2005; Buck Louis, Gray et al. 2008; Euling, Selevan et al. 2008; 
Wolff, Britton et al. 2008). Alterations in the timing of puberty have been associated with 
important public health concerns such as modifications in physical growth of children 
(Ong, Northstone et al. 2007), metabolic (Frontini, Srinivasan et al. 2003) and 
cardiovascular diseases (Lakshman, Forouhi et al. 2009), and certain cancers (Golub, 
Collman et al. 2008; Dossus, Allen et al. 2010; Karageorgi, Hankinson et al. 2010) 
among adults.  
Lead exposure in adolescence has been associated with delays in the timing of 
puberty in cross-sectional studies in nationally representative samples of U.S. females in 
NHANES III (Selevan, Rice et al. 2003; Wu, Buck et al. 2003; Gollenberg, Hediger et al. 
2010). Selevan and colleagues (2003) found that concurrent blood lead levels were 
associated with significant delays in both breast (n=1986) and pubic hair (n=1964) 
development among African-American and Mexican-American but not among white 
girls. Among 1796 girls aged 8-16 years, blood lead levels of 3 µg/dL were associated 
with a 3.6-month delay in age at menarche compared with blood lead levels of 1 µg/dL; 
this finding however, was only observed among African-American girls (Selevan, Rice et 
al. 2003). Girls with blood lead levels between 2.1–4.9 µg/dL had a 52% reduced odds of 
having developed pubic hair and 58% reduced odds of having attained menarche as 
compared with girls with lower blood lead levels (0.7-2.0 µg/dL) (Wu, Buck et al. 2003). 
Among 138 Akwesasne Mohawk girls in New York State, lead levels above the 
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geometric mean (0.49 µg/dL) were correlated with a lower likelihood in attainment of 
menarche (Denham, Schell et al. 2005).  
Among boys, evidence of delayed pubertal onset is sparser: just one study in 
Russia suggests a differential association of lead by pubertal characteristic: In 489 
Russian boys aged 8-9 years, those with blood lead levels greater than or equal to 5 
µg/dL had a 44% reduced odds of having entered Tanner genital stage G2 (Hauser, 
Sergeyev et al. 2008). Blood lead levels were marginally significantly associated with 
decreased testicular volume but not with Tanner pubic hair stage P2 or higher (Hauser, 
Sergeyev et al. 2008). In the longitudinal follow-up of this cohort, baseline blood lead 
levels higher than 5 µg/dL were related to an approximate 24% and 27% decrease, 
respectively, in the likelihood of pubertal onset as measured by G2 or higher and 
testicular volume greater than 3 mL. Blood lead levels were marginally significantly 
associated with a 31% reduction in the likelihood of pubertal onset measured by P2 or 
higher (Williams, Sergeyev et al. 2010).  
 
This paper aims to address a research gap identified by an expert panel (Buck 
Louis, Gray et al. 2008) by examining the association of prenatal lead exposure with 
puberty onset. We report here on our prospective study design and preliminary findings 











The study population is derived from an on-going longitudinal birth cohort study 
in Mexico City. Study methods have been extensively described elsewhere (Gonzalez-
Cossío, Peterson et al. 1997; Hernández-Avila, Peterson et al. 2002; Téllez-Rojo, 
Hernández-Avila et al. 2004; Ettinger, Lamadrid-Figueroa et al. 2009). Briefly, 
participants were recruited between 1994 and 2004 using similar methods and followed 
from birth to 5 years of age. Participants were then invited to participate in a later follow-
up study in 2007. Exclusion criteria for the later follow-up study included having 
epilepsy or autism. All study participants completed a questionnaire on self-reported 
sexual maturation (described in detail below). Of the 95 children who filled out the 
questionnaire, 75 had a corresponding maternal patella bone lead measurement obtained 
at 1-month postpartum. One participant was excluded due to a biologically implausible 
value for BMI z-score. In this paper, we report preliminary results of 74 participants, 
which include 43 girls and 31 boys.  
 
The study was approved by the Institutional Review Board at the University of 
Michigan and the Ethics Committee of the National Institute of Public Health in Mexico. 
The mother or guardian accompanying the child signed a consent form and the child 




Self-Reported Sexual Maturation 
 
We developed a questionnaire for self-report of sexual maturation based on 
adaptations to the original Tanner stages (Tanner 1962) with figures (obtained with 
permission from Taylor, Whincup et al. 2001; personal communication 9-29-08), and 
descriptions (obtained from Bonat, Pathomvanich et al. 2002; personal communication 
with senior author Margaret Keil 6-18-08) depicting the 5 Tanner stages. The 
questionnaire was translated into Spanish and reviewed by native speakers and field staff. 
It was first piloted among 12 participants aged 7 to 14 years old, and then given to the 
study population.  
 
Self-reported sexual maturation has been extensively used in population studies 
(Jones, Hitchen et al. 2000; Rapkin, Tsao et al. 2006; Rubin, Maisonet et al. 2009) and 
specifically in Mexico (Posadas-Sánchez, Posadas-Romero et al. 2007; Denova-
Gutiérrez, Jiménez-Aguilar et al. 2008). In population studies, self-reported sexual 
maturation has been correlated with physician-observed Tanner staging (Brooks-Gunn, 
Warren et al. 1987; Schlossberger, Turner et al. 1992). Some studies among obese 
adolescents’ self-reported Tanner stages (Bonat, Pathomvanich et al. 2002; Lee, Valeria 
et al. 2006), but not others (Taylor, Whincup et al. 2001) found that fat tissue could be 
misinterpreted as breast tissue. 
 
We used the self-reported sexual maturation figures from Taylor et al. (2001) 
because among boys the ratings for genital development are separate from pubic hair, 
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clearly distinguishing the effect of gonadal hormones (genital and breast development) 
and adrenal hormones (pubic hair). Through hypothalamic-pituitary-gonadal (HPG) axis 
hormone signaling the gonads are stimulated to produce androgen and estrogen which 
lead to the development of the penis, testes, breasts, ovaries, and uterus and also to the 
secondary sexual characteristics, such as pubic hair. Pubic hair development is also 
controlled by androstenedione and dehydroepiandrosterone (DHEA) released by the 





The study visit included anthropometry and administration of self-reported sexual 
maturation questionnaire. The child psychologist explained the objective of the 
questionnaire to the mother and showed her a sample of the figures stating that they will 
ask their child if he/she would like to have them present in the room while he/she fills out 
the questionnaire. The psychologist then asked the mother if she would like to discuss the 
questionnaire with the child before he/she fills it out. The psychologist went through the 
questionnaire with the child and left him/her alone in the room. Children were asked to 
select their self-perceived stage of development by choosing the drawings and 
descriptions closest to their current stage of sexual development. Girls were asked to 
report their attainment of menarche. Both boys and girls reported any practices of pubic 
hair shaving as this might bias their self-reported Tanner staging. The questionnaire was 
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folded after completion. This allowed children confidentiality, privacy, and comfort with 
answering these sensitive questions.  
 
Bone Lead Measurement 
 
Maternal bone lead was assessed at 1-month postpartum using in vivo K-X-ray 
fluorescence (K-XRF). Measurements were obtained at the mid-tibial shaft (cortical 
bone) and the patella (trabecular bone) and reported in g lead/g bone mineral. The 
instrument and validation have been extensively described (Burger, Milder et al. 1990; 
Hu, Milder et al. 1991; Aro, Todd et al. 1994; Hu, Aro et al. 1995). 
 
Statistical analyses  
 
Multivariable logistic regression was used to assess the association of prenatal 
lead exposure with puberty onset (Wu, Buck et al. 2003). Children were classified having 
entered puberty (dichotomous variable) if their self-reported Tanner stage was at or above 
2. Our pubertal onset outcomes of interest were comprised of breast development greater 
than Tanner stage 2 for girls (denoted as B2), genitalia for boys (G2), and pubarche for 
both genders (P2). 
Age-specific BMI and height z-scores were calculated using the SAS macro based 
on the 2007 World Health Organization (WHO) growth reference standards for 5-19 year 
olds (de Onis, Garza et al. 2007). Biologically implausible values were identified for 
height-for-age (defined as < -6 or > 5) and BMI-for-age (defined as < -5 or > 5) z-score. 
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Models were adjusted for child age at visit and maternal education (Wronka and 
Pawlińska-Chmara 2005). Given the limited sample size of children who had entered 
puberty, we could only include a maximum number of 1 predictor in the pubic hair 
regression models and 2 predictors in the breast and genitalia regression models (Peduzzi, 
Concato et al. 1996). Therefore, we adjusted for child’s age in the pubic hair models; and 
for child’s age and maternal education in the breast and genitalia development models. 
Because BMI has been related to pubertal onset in a number of studies (Kaplowitz, Slora 
et al. 2001; Wang 2002; Davison, Susman et al. 2003; Lee, Appugliese et al. 2007), we 
adjusted for BMI-for-age z-score in the second model in exploratory analyses. Analyses 
were conducted for patella lead due to a smaller sample size of tibia measurements. Data 




Demographic and pubertal characteristics of 53 girls and 41 boys are shown in 
Table IV-1. Children were between 6.5 and 15.5 years old. Average patella lead was 11.2 
µg Pb/g (SD= 11.0) for girls, and 8.4 µg Pb/g (SD= 8.7) for boys. Mothers had, on 
average, 11 years of education. Among girls, mean age was 8.9 (SD= 1.9) years; 38% 
were at stage B2 or above and 19% at stage P2 or above. Mean reported age at menarche 
among 6 girls was 10 years old. Among boys, mean age was 9.7 (SD= 2.5) years; 59% 
were at stage G2 or above and 17% at stage P2 or above. Most children reported not 




The logistic regression models depicted in Table IV-2 revealed that maternal 
patella lead was not associated with puberty onset. The direction of effect for maternal 
patella lead with boys’ pubic hair was in the opposite direction than with boys’ genitalia, 
girls’ breast and pubic development. Adjusting for child’s age, for each 1 µg Pb/g 
increase in patella lead, boys had a 6% reduced odds of having entered stage P2 (95% 
CI= 0.68 to 1.30). After controlling for child's age at visit and maternal education, girls 
had a 5% increased odds of being in B2 for a 1 µg Pb/g increase in maternal patella lead 
(95% CI= 0.97 to 1.13) (Table IV-2).   
Child BMI was not associated with either maternal bone lead or puberty in this 
study. When including child BMI-for-age z-score in addition to child age and maternal 
education as predictors of puberty onset (for B2 and G2 outcomes), the effect estimates 
for patella lead were somewhat smaller, but not notably different than models without 




This is the first study to investigate the association of prenatal lead exposure, as 
measured by maternal bone lead, with pubertal onset as well as the first prospective study 
on lead’s impact on puberty among both boys and girls. The small sample size available 
for this preliminary analysis limited inferences. Maternal patella lead was not related with 
an increased odds of delayed pubarche and breast development among girls and genitalia 
development among boys.  
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Maternal patella lead was not significantly associated with delayed pubertal onset 
as measured by stage P2 or greater, among boys. In the Chapaevsk, Russia cohort study, 
child blood lead levels ≥ 5 µg/dL at 8-9 years among 461 boys were marginally 
significantly associated with a 31% reduction in the likelihood of pubertal onset in the 
longitudinal follow-up at 8 to 12 years of age measured by pubic hair staging 2 or higher 
(95% CI= 0.44 to 1.07) (Williams, Sergeyev et al. 2010). Child blood lead levels ≥ 5 
µg/dL at 8-9 years were also associated with a 24% and 27% decrease in the likelihood of 
pubertal onset at 8 to 12 years as measured by genitalia staging 2 or higher (95% CI= 
0.59 to 0.98) and testicular volume greater than 3 mL (95% CI= 0.55 to 0.97), 
respectively (Williams, Sergeyev et al. 2010).  
Mean age at menarche in our cohort (10.1, SD= 1.5) was younger than among 312 
Mexican Americans 8 to 16 year old (12.2, 95% CI= 12.1 to 12.4) (Selevan, Rice et al. 
2003). Age distribution of puberty onset was not comparable to U.S. nationally 
representative data of Mexican Americans in NHANES III (Sun, Schubert et al. 2002). 
Among girls, mean age at stages P2 and B2 were younger in our cohort (9.4, SD= 1.4 and 
9.0, SD= 1.5, respectively) than among 763 Mexican Americans aged 7 to 19 (11.2, SE= 
0.2 and 11.7, SE= 0.2, respectively). A similar observation was found among boys for 
stages P2 and G2 in our cohort (10.5, SD= 0.7 and 8.8, SD= 1.6, respectively) compared 
to Mexican Americans (12.2, SD= 0.2 and 11.1, SD= 0.2, respectively) (Sun, Schubert et 
al. 2002). 
 
Lead has been associated with increases in BMI in certain epidemiologic studies 
(Kim, Hu et al. 1995; Lamb, Janevic et al. 2008). In Chapter III of this dissertation, we 
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found that maternal patella lead was not associated with child’s BMI at 4 years of age. In 
this paper we found that maternal patella lead was still not a predictor of child BMI 
between 6.5 and 15.5 years of age. When including child BMI-for-age z-score as a 
predictor of B2 and G2, we found that the effect estimates were slightly reduced. 
However, child BMI-for-age z-score was not associated with any of the pubertal onset 
measures. 
 
Rodent studies suggest that lead may have dual sites of action: at the level of 
hypothalamic pituitary unit and directly at the level of gonadal steroid biosynthesis (Buck 
Louis, Gray et al. 2008). Lead is believed to act on the hypothalamic-pituitary-gonadal 
axis (HPG) by blocking the release of gonadotropin-releasing hormone (GnRH), thus, 
decreasing puberty-related hormones such as insulin-like growth factor-1 (IGF-1) (Ronis, 
Badger et al. 1998), luteinizing hormone (LH), and estradiol (Dearth, Hiney et al. 2002). 
At the gonadal steroid biosynthesis level, lead has been shown to impair Leydig-cell and 
Sertoli cell functions (Ronis, Gandy et al. 1998; Gorbel, Boujelbene et al. 2002). A recent 
nationally-representative cross-sectional study of U.S. females found that lead was 
related to a decrease in serum inhibin B levels, but not with LH levels (Gollenberg, 
Hediger et al. 2010). This result is indicative of lead’s direct action on the ovaries where 
inhibin B is produced (Gollenberg, Hediger et al. 2010).  
 
These preliminary findings must be interpreted in light of several limitations. We 
relied on self-report for Tanner stage assessment which might introduce information bias. 
Others have shown that boys may overestimate their genitalia development 
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(Schlossberger, Turner et al. 1992; Lee, Valeria et al. 2006). We found that the directions 
were different for P2 and G2 in relation to maternal patella lead. In addition, we 
conducted analyses stratified by sex, so any misclassification for the outcome (puberty 
onset) introduced by sex would likely be non-differential and thus tend to inflate the 
standard error coefficients. The study sample was comprised of a small number of 
participants and, thus, may be underpowered to detect an association of lead exposure 
with pubertal development. In addition, due to the small sample, our ability to control for 
additional covariates of interest, such as child nutritional status and maternal age at 





We found that maternal patella lead was not notably associated with pubertal 
onset among a small group of children followed prospectively since birth in Mexico City. 
However, given that these results are preliminary, we cannot rule out that prenatal lead 
exposure, as measured by maternal bone lead level, may be an important factor in 
pubertal onset. Since cumulative bone lead stores are long-lived, women and children 
may be exposed to lead even after environmental exposures have ceased. Future research 
will entail analyzing the association of prenatal lead exposure with onset of puberty 
among a larger sample of children from this cohort and include hormonal markers of 











Birth weight (kg) 51 3.0 0.4 38 3.2 0.6
Gestational age (months) 51 38.4 1.3 38 39.0 1.5
Child age at current visit (years) 53 8.9 1.9 41 9.7 2.5
Weight at current visit (kg) 53 32.3 9.8 41 38.1 15.1
Height at current visit (cm) 50 131.0 11.9 41 137.1 15.5
BMI-for-age z-score at current visit ¶ 50 0.8 1.0 41 1.1 1.4
Height-for-age z-score at current visit ¶ 50 0.0 0.8 41 0.2 0.8
Maternal education (years) 51 10.7 2.8 38 10.9 2.5
Lead Biomarkers
Maternal Patella (µg Pb/g) 43 11.2 11.0 31 8.4 8.7
Maternal Tibia (µg Pb/g) 31 11.9 10.7 20 6.8 7.3
Tanner Stages












Pubic hair stage 53 41
1 43 81.1 34 82.9
2 7 13.2 2 4.9
3 2 3.8 4 9.8
4 1 1.9 1 2.4
5 0 0.0 0 0.0
¶ Contructed using the SAS macro based on the 2007 WHO growth reference 

















Breast stage 2 or higher 43 1.04 0.97 , 1.11 43 1.05 0.97 , 1.13
Pubic hair stage 2 or higher 43 1.07 0.97 , 1.17
Boys
Genitalia stage 2 or higher 31 1.06 0.94 , 1.19 31 1.06 0.94 , 1.20
Pubic hair stage 2 or higher 31 0.94 0.68 , 1.30
‡ Association between 1 µg Pb/g patella lead increase and odds of puberty entry
a
 Adjusting for child's age at visit
b 
Adjusting for child's age at visit, and maternal education
Fully adjusted model ‡ 
b
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Lead exposure at current environmental levels continues to pose a public health 
concern. One of our research goals was to evaluate the association of prenatal lead 
exposure measured by a novel biomarker, maternal bone lead, with physical growth and 
maturation. The objective of Chapter II was to expand on the limited number of 
longitudinal studies considering the association of prenatal lead exposure with children’s 
weight from birth to school entry given that lead exposure has been more consistently 
associated with height than with weight. The aim of Chapter III was to disentangle the 
association of different windows of lead exposure susceptibility with height and BMI 
among children at 4 years old. Previous studies have investigated the longitudinal 
association of pre- and post-natal lead exposure during susceptible periods with height 
and BMI but only up until 33 months of age. In addition, only a limited number of studies 
have investigated the association of lead exposure with BMI, but none on childhood 
overweight or obesity. The goal of Chapter IV was to present preliminary results on the 
association of prenatal lead exposure with self-reported sexual maturation among a 




The results of Chapter II fill a gap in the literature as they expanded on previous 
findings. Maternal bone lead burden during pregnancy had been associated with weight 
decrements up to 1 month of age. We found that maternal bone lead was associated with 
decrements in child weight from birth to 5 years of age. We noted that this association 
was observed only among females and not males, highlighting lead might have a 
differential effect on physical growth by gender.  
 
Because variance in weight can be related to height or the relationship of weight 
for height (proportionality), we investigated in Chapter III the association of lead 
exposure with height and BMI. We were able to disentangle the effect of prenatal from 
postnatal lead exposure on attained height and BMI at 4 years of age providing evidence 
on windows of lead exposure susceptibility of child growth. We hypothesized that the 
most susceptible window would be the prenatal and infancy periods. Instead, we found 
that the infancy (birth to 24 months) blood lead levels were most influential on attained 
height at 4 years. An alternative explanation for the results obtained could be that 
children’s blood lead levels have been found to peak around 24 months (Bellinger 2004). 
However, in our study, the mean blood lead level of children from birth to 24 months was 
lower than from 30 to 48 months. 
 
Future research directions for Chapters II and III would need to investigate 
whether those associations persist in adolescence. Specifically, would the weight and 
height decrements observed continue at or beyond adolescence (i.e., would prenatal or 
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infancy lead exposure be associated with adult height – following the adolescent growth 
spurt)? Would a latent effect on BMI, which we did not observe, emerge at later ages? 
 
In Chapter IV, we presented preliminary results of lead’s association with puberty 
onset among a subset of 43 girls and 31 boys aged 6.5 to 15.5 years. We described our 
study design and the development of self-reported sexual maturation ratings identifying 
gender-specific secondary sexual characteristics that reflect different aspects of hormonal 
control of development. The results suggest that lead exposure was not associated with 
delayed pubertal onset of boys or girls (measured by pubic hair, genitalia, and breast 
development). A limitation of this study was the small sample size. 
 
Future work will analyze the association of concurrent lead exposure (as 
measured by child blood lead) on puberty onset. Future research will involve 
administration of the self-reported questionnaire through continued follow-up in the 
longitudinal study. Further, a validation study will shed light on the reliability of the self-
reported questionnaires as compared to physician ratings of Tanner staging. 
 
How do these results relate to health policies regarding lead? Currently the CDC’s 
blood lead level of concern is set at 10 µg/dL (CDC 1991). It is not a threshold level or a 
health standard but, instead, a prompt for action to decrease child lead exposure by 
providing caregivers education, and triggering environmental investigation and follow-up 
testing (Committee on Environmental Health 2005; Advisory Committee on Childhood 
Lead Poisoning Prevention 2007). Blood lead levels less than 10 µg/dL have been shown 
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to be associated with numerous adverse health effects (Canfield, Henderson et al. 2003; 
Téllez-Rojo, Bellinger et al. 2006; Surkan, Zhang et al. 2007). In Chapter III, child blood 
lead levels (mean= 5.3 µg/dL, SD= 2.8) was associated with decrements in attained 
height at 4 years of age. Because of the absence of a blood lead level threshold for health 
effect, the Agency for Toxic Substances and Disease Registry (ATSDR) has not set a 
minimum risk level (MRL) nor has the Environmental Protection Agency (EPA) put forth 
a reference dose (RfD) (ATSDR 2007). However, some researchers are advocating for a 
decrease in the CDC’s blood lead level of concern from 10 µg/dL to 5 µg/dL, which the 
CDC has so far declined to do (Bellinger 2008; CDC 2009). Our data supports this 
decrease. Others are arguing for a decrease to 2 µg/dL (Gilbert and Weiss 2006). The 
proposal to decrease the CDC’s level of concern from 10 µg/dL to 5 µg/dL or 2 µg/dL 
levels has less to do with the biological significance of these levels than with the 
prevention of lead poisoning. There is no longer significant doubt in the majority of the 
scientific community that low-lead exposure as measured by child blood lead levels 
below 10 µg/dL is associated with detrimental health outcomes. The translation of this 
information, however, is arguably constrained by political and policy considerations. 
Currently, there are no health policies setting a level of concern for maternal bone 
lead concentrations. In Chapter II, we found that prenatal lead exposure, measured by 
maternal bone lead, was associated with decrements in weight. The publications from this 
research will hopefully contribute to the epidemiological evidence that maternal bone 
lead burden is associated with detrimental effects on offspring anthropometry. Efforts to 
develop recommendations related to maternal lead burden are ongoing, including the 
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imminent release of the long-awaited report of the CDC Committee on Lead and 
Pregnancy (CDC 2010). 
 
The effect of lead on growth and development may be generalized to developing 
countries that have recently phased-out leaded gasoline (for example, the use of leaded 
gasoline was reduced in Lebanon in 2000). Given the long retention time of lead in the 
bones, the detrimental effects associated with lead exposure are far from being over. 
Other modern environmental health hazards (Nweke and Sanders III 2009) such as such 
as pesticides (dichlorodiphenyltrichloroethane or DDT) and polychlorinated biphenyls 
(PCBs), affect growth through endocrine disruption (Brucker-Davis, Wagner-Mahler et 
al. 2010; Schell and Gallo 2010). Emerging contaminants such as bisphenol A (BPA) and 
phthalates could potentially have consequences on reproductive health (Meeker, Hu et al. 
2009). In addition, exposure to metal mixtures (or other contaminants such as 
manganese) and genetic susceptibilities may also play a role in growth and development. 
Understandably, not all possible factors can be accounted for in population studies. 
However, it is important to place this dissertation into perspective, and keep in mind that 
the goal of this dissertation was to shed light on the longitudinal effect of pre- and post-
natal lead exposure. The results of this research are applicable to future policies on the 
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